Doctors are coming around to Teva's Austedo as TD drugs get more play: analyst

11th June 2018 Uncategorised 0

In the brand-new tardive dyskinesia market, doctors initially preferred Neurocrine’s Ingrezza over Teva’s Austedo. But that edge is weakening, one analyst says.

More: Doctors are coming around to Teva's Austedo as TD drugs get more play: analyst
Source: fierce